Muscle Relaxant Drugs Market: Global Size, Trends, Competitive, Historical &Forecast Analysis, 2020-2026– Increasing prevalence of lower back pain with surge in number of surgeries in geriatric population as well as rising healthcare expenditures of relaxant drugs are expected to boost the growth of muscle relaxant drugs market over forecast period.
Global Muscle Relaxant Drugs Market is valued at USD 1710.70 Million in 2018 and expected to reach USD 2775.90 Million by 2025 with the CAGR of 7.16% over the forecast period.
Scope of Global Muscle relaxant drugs Market Report –
The muscle relaxant is a drug that affects skeletal muscle function and decreases the muscle tone. They may be new to alleviate symptoms such as muscle spasms, pain, and hyperreflexia. Further, muscle relaxant drugs are highly restricted to consume by pregnant women, old person and other drug or alcohol addicted persons. The muscle relaxant drugs are primarily used in conjunction with general anesthetics to achieve muscle relaxation during surgical interventions. Conversely, they are also being used in the treatment of muscle spasm and spastic neurological conditions secondary to multiple sclerosis, cerebral palsy, fibromyalgia, myofascial pain syndrome etc. These drugs exert their muscle-relaxing effects by inhibiting nerve signals in the brain and spinal cord and may help break the pain-spasm-pain cycle, where pain causes your muscles to spasm as a protective response, and those spasms, in turn, cause more pain. Additionally, while treating acute musculoskeletal back pain, a short course of muscle relaxants may be more effective when used as an adjunctive treatment in the first 3 weeks. They may also be used when back pain causes disturbed sleep for their sedative effect. Muscle relaxants can be addictive, so it’s ideal to use them for the shortest possible time and keep them away from other adults and children. Because these medications depress the central nervous system, breathing can be affected, and an overdose can be fatal.
Get Sample Copy of This Premium Report @ https://industrystatsreport.com/Request/Sample?ResearchPostId=1056&RequestType=Sample
Global muscle relaxant drugs market report is segmented on the basis of type, application, and by regional & country level. Based on type, global muscle relaxant drugs market is classified as the facial muscle relaxant drugs, skeletal muscle relaxant drugs and neuromuscular blocking agents. Based upon application, global muscle relaxant drugs market is classified into Hospital Pharmacy, Retail Pharmacy and Online Pharmacy
The regions covered in this muscle relaxant drugs market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, market of clinical decision support system is sub divided into U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.
Key Players for Global Muscle relaxant drugs Market Report-
Some major key players for global muscle relaxant drugs market are Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., Intas Pharmaceuticals Ltd., Galderma S.A., F. Hoffmann-La Roche Ltd and others.
FIZER AND LILLY RECEIVE FDA FAST TRACK DESIGNATION FOR TANEZUMAB
Pfizer Inc. and Eli Lilly and Company has been announced that the U.S. food and drug organization (FDA) has granted Fast Track designation for tanezumab for the treatment of chronic pain in patients with osteoarthritis (OA) and chronic low back pain (CLBP). Hence, the Tanezumab is an investigational humanized monoclonal antibody that selectively targets, binds to and inhibits nerve growth factor (NGF). However, the first NGF inhibitor to receive Fast Track designation, a process designed to facilitate the development and expedite the review of new therapies to treat serious conditions and fill up unmet medical requirements. Furthermore, the tanezumab would be the first in a new class of non-opioid chronic pain medications,” said Ken Verburg, Chief Development Officer, Neuroscience & Pain, Pfizer Global Product Development. They believe it would represent an important medical advance in the treatment of debilitating osteoarthritis and chronic low back pain for patients who do not experience adequate pain relief or cannot tolerate currently available pain medications.
Request for Methodology @ https://industrystatsreport.com/Request/Sample?ResearchPostId=1056&RequestType=Methodology
Global Muscle Relaxant Drugs Market Dynamics –
Rising prevalence of musculoskeletal problems and growing awareness amongst the consumers regarding their treatment and management are expected to be the dynamic factors behind the growth of global market of muscle relaxant drugs. According to the World Health Organization (WHO), the non-specific burden of lower back pain has been increased substantially around the globe which is estimated at 60–70% in industrialized countries whereas one-year prevalence increasing rate 15–45%, adult incidence 5% per year and mostly occurrence of LBP has seen in above 35 age group people. However, severe side effects related to muscle relaxant drugs such as habituation and respiratory arrest will restrict the growth of global muscle relaxant drugs market. The recent technologically improved muscle relaxants are structurally distinct drugs prescribed for reducing muscle spasms, pain, and hyperreflexia. Centrally acting skeletal muscle relaxants are manufactured by various pharmaceutical companies with variable price. The present study, aimed to analyze the cost variation of various brands of centrally acting skeletal muscle relaxants, so as to help the physician to choose the cost effective treatment to drive the market growth.
Global Muscle Relaxant Drugs Market Regional Analysis –
Geographically, North America is dominating the highest share, in terms of profits in overall market of muscle relaxant drugs across the global. The global market for muscle relaxant drugs is expected to gain traction during the forecast period due to increasing aging population and availability of generic drugs. According to the World Health Organization (WHO), America has more than 50% of the aging population estimated to about 1.2 million and is expected to rise up to 1.9 Million by 2030.The Asia Pacific muscle relaxant drugs market is envisioned to grow at fastest pace during the forecast period. Factors such as growing geriatric population and rising number of surgeries are projected to bolster the growth of muscle relaxant drugs market in Asia Pacific region. China, India & Japan are likely to contribute significantly in growth of market. According to the World population, the U.S. has highest aging population with the estimated population from 143 million in 2019 to 426 million in 2050 followed by Asia Pacific
Key Benefits for Global Muscle relaxant drugs Market Reports–
Global Muscle relaxant drugs Market report covers in depth historical and forecast analysis.
Global Muscle relaxant drugs Market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Market Restraints, Market opportunities, Competitive Analysis, Regional and Country Level.
Global Muscle relaxant drugs Market report helps to identify opportunities in market place.
Global Muscle relaxant drugs Market report covers extensive analysis of emerging trends and competitive landscape.
Global Muscle relaxant drugs Market Segmentation –
Global Muscle relaxant drugs Market: By Type
Facial Muscle Relaxant Drugs
Skeletal muscle Relaxant Drugs
Neuromuscular Blocking Agents
Global Muscle relaxant drugs Market: By Application
Global Muscle relaxant drugs Market: By Regional & Country Analysis
The Middle East and Africa
Rest of Middle East and Africa
About us: Brandessence Market Research and Consulting Pvt. ltd.
Brandessence market research publishes market research reports & business insights produced by highly qualified and experienced industry analysts. Our research reports are available in a wide range of industry verticals including aviation, food & beverage, healthcare, ICT, Construction, Chemicals and lot more. Brand Essence Market Research report will be best fit for senior executives, business development managers, marketing managers, consultants, CEOs, CIOs, COOs, and Directors, governments, agencies, organizations and Ph.D. Students. We have a delivery center in Pune, India and our sales office is in London.
Contact us at: +44-2038074155 or mail us at firstname.lastname@example.org